Apologies for fragmented post.
The clinical results from the recent trials do provide evidence of the pre - post clinical findings (impressive and significant improvements achieved with the DURAVR). The clinical results also show superiority over the competitors products...specifically, the mechanical readings - area of valve and pressure gradient.
The cited article (sample of 80 in two groups - mechanical v bioprosthetic valves) highlited a difference between the two......particularly with the exercise tollerence results......the patients recieving the mechanical valve achieved significant improvements in the 6 minute walk test, yet the bioprosthetic valve shows no improvement.
Perhaps this is another area of superiority our product has - the bioprosthetic valve space.
Apologies for fragmented post.The clinical results from the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.00 |
Change
0.110(0.58%) |
Mkt cap ! $365.2M | |||
| Open | High | Low | Value | Volume |
| $19.01 | $19.11 | $18.59 | $97.55K | 5.216K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 43 | $19.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.50 | 21 | 1 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |